TLDR
- Strategy shares plunged to $97.30 on Wednesday, marking the lowest level since March 2024, declining approximately 5.5% during the session
- The flagship cryptocurrency tumbled to approximately $60,935, representing a two-week nadir and a decline exceeding 50% from the October peak above $126,000
- The company liquidated 2.71 million shares last week, generating $335.5 million in proceeds, with the majority allocated to cash reserves rather than Bitcoin acquisitions
- Preferred stock dividend commitments have escalated to $1.2 billion annually, sparking concerns about potential Bitcoin liquidation to meet obligations
- Schiff cautioned that aggressive short-selling activity could compel Saylor to divest Bitcoin holdings for share buybacks, potentially triggering further crypto market deterioration
Longtime Bitcoin skeptic Peter Schiff has his eyes fixed on MSTR’s current predicament ā and market observers are paying close attention.
Shares of Strategy (MSTR) breached the $100 threshold on Wednesday, marking the first occurrence since March 2024. The stock bottomed at $97.30 during early trading hours and was hovering near $98.05, representing a decline of approximately 5.5% for the session.
This places MSTR approximately 20% lower across the previous five sessions and more than 38% down throughout the past month.
The previous instance of MSTR trading beneath the $100 mark occurred on March 1, 2024, during a period when Bitcoin was similarly positioned in the $61,000 to $62,000 territory.
Bitcoin descended to $60,935 on Wednesday, establishing a two-week floor. The leading digital asset by market capitalization reached heights exceeding $126,000 last October before surrendering over half its valuation.
The cryptocurrency has faced sustained selling pressure as capital flows out of Bitcoin exchange-traded funds toward artificial intelligence equities. The Federal Reserve’s increasingly restrictive monetary policy stance has compounded these challenges.
Share Dilution Concerns Mount
Strategy divested approximately 2.71 million shares during the previous week, securing roughly $335.5 million in capital. The bulk of these proceeds were directed toward replenishing cash holdings rather than cryptocurrency purchases.
The enterprise allocated $300 million to its dollar reserves, elevating the aggregate to $1.4 billion. Executive Chairman Michael Saylor indicated the liquidity enhancement bolsters the creditworthiness of Strategy’s Digital Credit instruments.
Merely a nominal amount ā $35 million ā was deployed for acquiring 520 BTC. This represents a significant departure from the company’s typical acquisition velocity and has drawn market scrutiny.
Strategy’s preferred equity instrument STRC, engineered to maintain proximity to $100, plummeted to $82.53 during the previous week. The security was changing hands around $84.35 on Wednesday, declining 3.4% intraday. The corporation’s yearly dividend commitments on preferred securities have now swelled to $1.2 billion, prompting speculation regarding future funding mechanisms.
Schiff Issues Cautionary Prediction
Peter Schiff provided commentary on X, cautioning that aggressive short-selling campaigns might drive MSTR sufficiently low to corner Saylor strategically. “If short sellers push $MSTR’s price low enough, they can put Saylor in a position where his best option would be to sell Bitcoin to buy back stock,” Schiff articulated.
He continued by noting such actions “would reduce the discount” on MSTR shares but cautioned that “Bitcoin will crash” should Strategy face compulsory liquidation of its cryptocurrency reserves.
Strategy executed its inaugural Bitcoin divestiture since 2022 earlier this month, abandoning its longstanding “accumulate indefinitely” philosophy. This decision undermined investor sentiment and aligned temporally with Bitcoin’s descent beneath $70,000.
Strategy’s year-to-date performance registers at -31.66%. The company’s market capitalization currently stands at roughly $38.36 billion. Average session volume approximates 18.6 million shares.
Technical analysis indicators for MSTR presently signal a Sell recommendation.


